On this study we describe a landscape of genomic alterations in lung adenocarcinoma patients with WSE in the tumor suppressors SMARCB1 and ATM, in addition to the oncogenes EGFR, RET and KDR. Here, SMARCB1 is linked to lung adenocarcinoma.